Cosmetic News In Brief: J&J Incurs Third Talc Trial Loss; Lauder Acquires BECCA; More
This article was originally published in The Rose Sheet
J&J again failed to convince a St. Louis jury that available evidence does not support alleged links between its Johnson’s Baby Powder and cases of ovarian cancer, marking the third costly loss in the Missouri circuit court this year; More cosmetics news in brief.
You may also be interested in...
Companies marketing “self-preserving” cosmetics could be susceptible to lawsuits at a time when “no injury” product liability class actions are on the rise. Meanwhile, “preservative-free” claims already are being challenged in the food sector where litigation trends often originate before migrating to personal care.
A new defense team for J&J got the job done March 3 in the same Missouri court where juries handed down hefty verdicts against the firm last year for failing to warn about talc’s alleged carcinogenicity. This time, the defendant appears to have been successful in punching holes in plaintiff experts’ testimony.
A planned restage of Johnson’s Baby will “completely reinvent the brand,” says Jorge Mesquita, global chairman of the J&J’s consumer division. Meanwhile, the firm is working to unfetter “captive” regional brands, expanding OGX and Aveeno across the globe while bringing Le Petit Marseillais to North America, among other growth initiatives.